Solar elastosis correlates with high tumor mutation burden and better 5-year disease-specific survival in patients with stage II/III melanoma
The association of solar elastosis to TMB and 5-year melanoma specific survival points to its potential as a biomarker of clinical relevance that can be assessed by routine histopathology.
Authors
- Li Luo (ORCID: https://orcid.org/0000-0003-0728-8628)
- Klaus J. Busam (ORCID: https://orcid.org/0000-0003-0888-9601)
- Nancy E. Thomas (ORCID: https://orcid.org/0000-0002-2230-1328)
- Marianne Berwick (ORCID: https://orcid.org/0000-0001-5062-2180)
- Irene Orlow (ORCID: https://orcid.org/0000-0001-6234-6961)
- Cecilia Lezcano (ORCID: https://orcid.org/0000-0001-9436-9623)
- Ronglai Shen (ORCID: https://orcid.org/0000-0002-8192-7531)
Institutions
- University of North Carolina at Chapel Hill (US)
- Memorial Sloan Kettering Cancer Center (US)
- New Mexico Cancer Center (US)
- UNC Lineberger Comprehensive Cancer Center
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1016/j.ejcskn.2024.100274
- Citations
- 1
- Primary Topic
- Skin Protection and Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.53
Funders
- Yale University
- Memorial Sloan-Kettering Cancer Center
- Cleveland Clinic
- Dartmouth College
- Huntsman Cancer Institute
- Dartmouth Cancer Center
- York University
- Melanoma Institute Australia
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- University of North Carolina at Chapel Hill
- National Cancer Institute